Objective The objective of this study was to compare national guidelines on the prevention
of RhD alloimmunization. Study Design We performed a review of four national guidelines …

Providers who treat patients with chronic pain face a dual challenge: providing adequate
access to opioid therapies for appropriate pain management while adopting strategies to …

Abstract BACKGROUND Rhesus D (RhD) incompatibility is still the most important cause of
hemolytic disease of the fetus and newborn (HDFN) worldwide. The aim of this study was to …

Objective The purpose of this study was to identify midwives' attitudes towards women using
substances during pregnancy, which informed the development of an integrated care …

Background Data on the relationship between the dose of opioid replacement therapy in
pregnancy and the risk and severity of neonatal opioid withdrawal syndrome are conflicting …

Delayed hemolytic transfusion reaction (DHTR) is a complication appearing a few days to
weeks due to alloimmunization following packed red blood cells (RBCs) transfusion, a …

Hemolytic disease of the fetus and newborn (HDFN) remains an important cause of perinatal
morbidity and mortality. HDFN is caused by maternal alloimmunization to red blood cell …

Objetivos: capacitar a los profesionales de la salud involucrados en la atención de la mujer
gestante con Rh-D (-), con el fin de estandarizar el manejo de la prevención de la …

Maternal alloimmunization is the presence of non-AB antibodies in the-pregnant woman, in
some cases putting her fetus at risk for hemolytic disease of the fetus and newborn. While …

Objective: The objective of this study was to compare the frequency and percentage of fetal
hemoglobin (HbF%) by flow cytometry of (1) first-trimester asymptomatic patients with …